S&P assigns ‘AA-‘ rating to Nebraska Medicine’s bonds

S&P Global Ratings has assigned an “AA-” rating to Omaha-based Nebraska Medicine’s $130.7 million of series 2016 bonds and $136.4 million of series 2016 bonds.

Advertisement

“The ‘AA-‘ rating reflects our view of such factors as Nebraska Medicine’s position as the premier academic medical center in the growing Omaha service area, strong operating margins, very good coverage and stable balance sheet,” said S&P analyst Kevin Holloran.

The outlook is stable, reflecting S&P’s view of Nebraska Medicine’s strong credit fundamentals, solid business position and strengthening financial profile.

More articles on healthcare finance:
Senator asks CMS to delay ending Medicare payments for Ozarks Community Hospital
Bay Area Hospitalist Associates adopts Salar software to enhance charge capture
Hospitals’ 3 biggest revenue cycle mistakes

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

Reconsider What’s Possible: Enterprise RCM and the Pro-Fee Practice

Tuesday, July 28
11:00 AM - 12:00 PM CDT

Presenters: Garett Kreitz, Med-MetrixJohn Stefanowicz, Med-Metrix

Advertisement

Next Up in Financial Management

  • For decades, healthcare has searched for the next breakthrough. Better therapies. Better technologies. Better payment models. Better data. More recently,…

  • Tampa General Hospital hosted CMS Administrator Dr. Mehmet Oz on July 23 for a tour of the academic health system’s…

Advertisement

Comments are closed.